TEIJIN Ltd.
Japan Tissue Engineering Co., Ltd.
Mitsui Fudosan Co., Ltd.
National Cancer Research Center
(Headquarters: Kita-ku, Osaka; President: Tetsushige Uchikawa; hereinafter "Teijin"), Japan Tissue Engineering Co., Ltd. (Headquarters: Gamagori City, Aichi Prefecture; President: Kenichiro Hata; hereinafter "J-TEC"), Mitsui Fudosan Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President: Masanobu Komoda; hereinafter "Mitsui Fudosan") and National Cancer Research Center (Headquarters: Chuo-ku, Tokyo; President: Chuo-ku, Tokyo; President: Tadashi Nakagama; hereinafter "NCC") have signed a contract to develop a one-stop business for the development of Kashiwa City, with the aim of creating innovative treatments for unsolved diseases such as cancer and the development of Kashiwa City. In particular, we aim to accelerate the commercialization of products such as regenerative medicine related to cancer and contribute to society through the provision of innovative treatments originating in Japan.
Click here for more information